Question
Classify Oral Anti diabetic drugs. Describe the mechanism of action, therapeutic uses and adverse effects of Metformin. (2+2+1+1)2. A 30 years old male patient admitted to hospital with a complaint of fever with chills since 5 days. Severe headache and yellowish discolouration of conjunctiva present. He is drowsy and irritable. Peripheral smear shows gametocytes of plasmodium falciparum. He is using chloroquine since onset of fever but fever not subsided.
(a) What is the diagnosis of the clinical condition 1 mark(s)
(b) Classify drugs used in malaria 2 mark(s)
(c) Describe the management of above condition 2 mark(s)
(d) Mention two regimens of artemisinin based combination therapy 1 mark(s)
Q1 6 marks Essays ★ ✓
Answer
Question 1 — Oral antidiabetic drugs and Metformin
Classification of oral antidiabetic drugs
Sulfonylureas: Glibenclamide, Glimepiride
Biguanides: Metformin
Alpha-glucosidase inhibitors: Acarbose
Thiazolidinediones: Pioglitazone
DPP-4 inhibitors: Sitagliptin
SGLT2 inhibitors: Dapagliflozin
Mechanism of action of Metformin
Reduces hepatic gluconeogenesis, increases peripheral insulin sensitivity/glucose uptake by tissues, and mildly decreases intestinal glucose absorption
Does not stimulate insulin secretion (insulin-independent action) — does not cause hypoglycaemia when used alone
Therapeutic uses
First-line drug for type 2 diabetes mellitus (especially in obese/overweight patients)
PCOS (off-label, improves insulin resistance)
Adverse effects
GI upset (nausea, diarrhoea) — common
Lactic acidosis (rare but serious, especially with renal impairment)
Vitamin B12 deficiency with long-term use
Contraindicated in renal failure, severe hepatic disease, conditions predisposing to hypoxia/lactic acidosis
Question 2 — Falciparum malaria case
(a) Diagnosis
Severe/complicated P. falciparum malaria with jaundice and cerebral involvement (drowsiness, irritability) — features suggestive of cerebral malaria, in a patient who has failed initial chloroquine therapy (indicating chloroquine-resistant P. falciparum)
(b) Classification of antimalarial drugs
Tissue schizonticides (causal prophylactic/radical cure): Primaquine, Proguanil
Blood schizonticides: Chloroquine, Quinine, Artemisinin derivatives, Mefloquine, Sulfadoxine-pyrimethamine
Gametocytocides: Primaquine, Chloroquine (except falciparum)
Sporontocides: Proguanil, Primaquine
(c) Management
This is a medical emergency — admit to ICU/high-dependency unit
IV Artesunate is the drug of choice for severe/complicated falciparum malaria (superior to IV quinine)
Supportive care: maintain airway/breathing/circulation, monitor for hypoglycaemia, manage fluid balance carefully (risk of pulmonary oedema/cerebral oedema), monitor renal function
Once the patient can tolerate oral therapy and is clinically stabilizing, complete treatment with a full course of oral ACT
Monitor for complications: acute kidney injury, severe anaemia, disseminated intravascular coagulation, hypoglycaemia
(d) Two ACT regimens
Artesunate + Sulfadoxine-pyrimethamine
Artemether + Lumefantrine
1 Diabetes Mellitus and Oral Hypoglycaemic Drugs
Other Years Asked
1 Classify Oral antidiabetic drugs. Discuss in detail any one group. Describe briefly Human insulin. Discuss the management of Diabetic Ketoacidosis. (4+3+4+4) 2023 January (Supplementary) (2019 Scheme) Essay · 15 marks 2 ( (a) Mention different groups of Anti-thyroid drugs available for clinical use. ( (b) Which anti-thyroid drug is used to treat hyperthyroidism in pregnancy. How it lowers thyroxine levels (i.e mechanism). What are its adverse effects. ( (c) Explain the rationale for use of propranolol in hyperthyroidism. ( (d) Briefly describe Insulin analogs. 2022 February (2019 Scheme) Essay · 15 marks 3 During routine medical check-up a 50-year male office executive with sedentary lifestyle was diagnosed to have developed type 2 diabetes mellitus. His fasting and post-meal blood glucose was 130 mg/dl and 190 mg/dl respectively, HbA1C was 7.8%, BP was 130/82 mm Hg and body mass index was 24 kg/m2. He was asymptomatic and investigations revealed no end organ damage. He was advised suitable diet, exercise and other lifestyle modifications. (a) Classify drugs used in type 2 diabetes mellitus giving suitable examples. (b) Which antidiabetic will you prescribe in this patient. Explain the pharmacological basis for the selection. Write the mechanism of action and adverse effects of the same. 2024 December (Supplementary) (2019 Scheme) Essay · 10 marks 4 ( (a) Enumerate Oral Anti diabetic drugs. Describe the mechanism of action, uses and adverse effects of any two groups. ( (b) Briefly describe Insulin analogs. 2024 March (Supplementary) (2019 Scheme) Essay · 10 marks 5 ( (a) Insulin analogs ( (b) ORS 2024 June (Supplementary) (2019 Scheme) Short Essay · 8 marks 6 ( (a) Selective Estrogen Receptor Modulators (SERMs). ( (b) Treatment of Diabetic Ketoacidosis. 2022 February (2019 Scheme) Short Essay · 8 marks 7 Classify Oral anti diabetic drugs. Write the MOA and adverse effects of sulfonyl urea. (2+2+2) 2023 March (Supplementary) (2010 Scheme) Essay · 6 marks 8 Classify oral anti diabetic drugs and explain the mechanism of action of any two groups. Mention one insulin analog and list one advantage of it over conventional insulin (2+3+1=6) 2016 October (Supplementary) (2010 Scheme) Essay · 6 marks 9 Classify oral hypoglycemic agents. Explain the mechanism of action and adverse effects of any one group. (2+2+2) 2017 August (Supplementary) (2010 Scheme) Essay · 6 marks 10 A 25years old insulin dependent diabetes mellitus patient develops sweating, anxiety, palpitations and tremors after performing vigorous exercise. Answer the following: (a) What is the cause of these symptoms. (b) Would you prescribe beta blockers to this patient if he develops hypertension and why. (c) How will you treat diabetic keto acidosis. 2016 February (2010 Scheme) Essay · 6 marks 11 Classify oral hypoglycemic drugs. Explain the mechanism of action, uses and side effects of sulfonylureas. (2+2+1+1) 2018 February (2010 Scheme) Essay · 6 marks 12 A 52-year-old patient visits his doctor with complaints of increased frequency of urination, increased hunger and thirst. His fasting blood sugar was 150mg/dl Postprandial blood sugar was 230mg/dl, HbA1c was 8%. A diagnosis of Type 2 diabetes was made…. (a) Classify Oral Anti diabetic drugs with two examples each. (b) Add a note on Biguanides 2024 March (Supplementary) (2010 Scheme) Essay · 6 marks 13 Enumerate the newer insulin analogues. What is the advantage of using insulin analogues over conventional insulin. How will you manage insulin resistance. (2+2+2) 2019 July (Supplementary) (2010 Scheme) Essay · 6 marks 14 A 68year old female patient, complains of easy fatigability for past 6 months. Routine checkup showed her fasting blood glucose level to be 168 mg/dL, glycosylated hemoglobin (HbA1 (a) Classify Oral anti diabetic drugs with two examples each (b) Briefly describe Metformin 2025 August (Supplementary) (2010 Scheme) Essay · 6 marks 15 Enumerate insulin analogues and tabulate their pharmacokinetic characteristics. 2025 March (Supplementary (SAY)) (2019 Scheme) Short Answer · 4 marks 16 Classify insulins according to the duration of action giving suitable examples. 2024 December (Supplementary) (2019 Scheme) Short Answer · 4 marks 17 Metformin. 2022 July (Supplementary) (2019 Scheme) Short Answer · 4 marks 18 Alpha glucosidase inhibitors 2014 March (2010 Scheme) Short Note · 3 marks 19 Insulin analogues. 2013 September (Supplementary) (2010 Scheme) Short Note · 3 marks 20 Vildagliptin 2021 February (Supplementary) (2010 Scheme) Short Note · 3 marks 21 Dipeptidyl peptidase 4 (DPP-4) inhibitors 2021 December (Supplementary) (2010 Scheme) Short Note · 3 marks 22 Sulfonylureas in type II diabetes mellitus. 2017 February (2010 Scheme) Short Note · 3 marks 23 Short acting insulin analogues 2022 May (Supplementary) (2010 Scheme) Short Note · 3 marks 24 Insulin analogs 2013 April (2010 Scheme) Short Note · 3 marks 25 Newer Insulins 2023 July (Supplementary) (2010 Scheme) Short Note · 3 marks 26 Dipeptidyl Peptidase 4 inhibitors 2022 October (Supplementary) (2010 Scheme) Short Note · 3 marks 27 Metformin 2021 December (Supplementary) (2010 Scheme) Short Answer · 1 mark 28 Insulin used in diabetic ketoacidosis 2018 July (Supplementary) (2010 Scheme) Short Answer · 1 mark 29 Longest acting insulin given as once daily dose 2015 February (2010 Scheme) Short Answer · 1 mark 30 Insulin analogues 2017 August (Supplementary) (2010 Scheme) Short Answer · 1 mark 31 Peroxysome proliferator activated receptor gamma agonists 2015 February (2010 Scheme) Short Answer · 1 mark 32 Metformin 2023 July (Supplementary) (2010 Scheme) Short Answer · 1 mark 33 Metformin 2024 August (Supplementary) (2010 Scheme) Short Answer · 1 mark 34 Short acting insulin analogues 2024 March (Supplementary) (2010 Scheme) Short Answer · 0.3 marks 35 Short acting Insulin analogues 2025 August (Supplementary) (2010 Scheme) Short Answer · 0.3 marks 36 Long acting Insulin analogues 2024 August (Supplementary) (2010 Scheme) Short Answer · 0.3 marks 37 Regular / Lente insulin in diabetic ketoacidosis Name the following (Two examples for each) (5x1=5) 2021 December (Supplementary) (2010 Scheme) Short Answer · 0.3 marks 38 Long acting Insulin analogs 2023 July (Supplementary) (2019 Scheme) Short Answer · 0.2 marks 39 Metformin/Sitagliptin for insulin resistance in a diabetic patient. 2024 March (Supplementary) (2019 Scheme) Short Answer · 0.2 marks